FIP

FIP
Name	FIP
Field	Veterinary medicine

FIP Feline infectious peritonitis (FIP) is a progressive, often fatal disease of domestic cats and some wild felids associated with a mutation of feline enteric coronavirus and a dysregulated host response. It presents in effusive ("wet") and non‑effusive ("dry") forms with variable systemic signs, and it has been a major concern for veterinarians, shelters, breeders, and conservationists. Clinical management, diagnostic strategies, and experimental therapies have evolved through research by institutions and investigators in veterinary virology and immunology.

Overview

FIP arises when a common viral agent undergoes transformation and interacts with host factors to produce severe multisystemic pathology. The underlying virus belongs to the family Coronaviridae historically studied alongside work on Maurice Hilleman‑era vaccine research and later comparative studies at centers like the University of California, Davis and the National Veterinary Services Laboratories. The disease has influenced practices in American Veterinary Medical Association‑affiliated clinics, shelter policies at organizations such as the Humane Society of the United States, and conservation programs working with Panthera species. Diagnostic tools and treatment protocols have been developed and debated among researchers at institutions including the Royal Veterinary College, Cornell University, and the University of Pennsylvania.

Cause and Pathogenesis

FIP is caused by internal mutation of feline enteric coronavirus (FECV), a ubiquitous alphacoronavirus related to other veterinary coronaviruses studied by teams at the World Organisation for Animal Health and research groups that previously characterized porcine epidemic diarrhea virus and canine coronavirus. Mutated variants gain the ability to replicate in monocytes and macrophages, promoting systemic dissemination. Pathogenesis involves viral tropism changes, immune complex formation, complement activation, and granulomatous inflammation mediated by cytokines investigated in immunology labs at institutions like the Pasteur Institute and the National Institutes of Health. Genetic susceptibility loci have been examined through comparative genomics collaborations with groups at The Wellcome Trust Sanger Institute and population studies analogous to work by the Broad Institute. Key pathological features include vasculitis, serosal inflammation, and pyogranulomas reminiscent of lesions described in comparative pathology at the American College of Veterinary Pathologists meetings.

Clinical Signs and Diagnosis

Clinical presentation ranges from the effusive form, with abdominal or pleural effusions noted by clinicians at referral hospitals such as Angell Animal Medical Center, to the non‑effusive form, with neurological, ocular, or organ‑specific signs seen in specialty clinics like those at Colorado State University Veterinary Teaching Hospital. Common signs include fever unresponsive to antimicrobials, weight loss, anorexia, and icterus documented in case series from veterinary centers including Ohio State University and University of Liverpool. Diagnostic approaches combine history, physical examination, hematology, serum biochemistry, acute phase proteins, effusion analysis, and molecular assays developed at laboratories such as Heska Corporation and academic virology units at University of Glasgow. Immunohistochemistry, reverse transcription PCR, and sequencing for spike gene mutations have been applied in diagnostic workflows similar to protocols used at the Centers for Disease Control and Prevention for other coronaviruses. Ancillary imaging at facilities like Massachusetts General Hospital‑affiliated veterinary units can assist in detecting effusions and organ changes.

Treatment and Management

Historically palliative care focused on immunosuppression with corticosteroids and supportive measures provided by practitioners in private practices and shelter medicine programs. Recent breakthroughs involve antiviral nucleoside analogs and 3C-like protease inhibitors tested in trials coordinated by investigators at institutions such as Iowa State University and private biotech companies that partner with academic centers like University of Florida. Experimental agents have shown promise in inducing remission in many cases, altering prognosis discussed at conferences like the International Veterinary Emergency and Critical Care Symposium. Management also emphasizes fluid therapy, nutritional support, analgesia, and treatment of secondary infections, with case management strategies shared through networks including the Veterinary Information Network.

Epidemiology and Risk Factors

FECV is widespread in multi‑cat environments documented in epidemiologic surveys from shelters and catteries associated with organizations like Best Friends Animal Society and national registries such as The Cat Fanciers' Association. Risk factors for mutation and clinical FIP include high-density housing, young age, stressors such as relocation and neutering programs, and certain breeds highlighted in studies from breed clubs and university genetics groups, including Cornell University breed susceptibility analyses. Outbreak investigations have involved public health‑style tracing similar to methods used by the Food and Agriculture Organization in zoonotic disease surveillance, although FIP is not considered zoonotic.

Prevention and Control

Control measures prioritize minimizing FECV transmission via hygiene, cohorting, and litter box management in facilities overseen by networks like Shelter Medicine Programs and breed registries. Screening and breeding recommendations have been promulgated by stakeholder organizations such as the International Cat Care and national veterinary associations including the British Veterinary Association. Vaccine development efforts have paralleled coronavirus vaccine research at centers like University of Oxford and commercial enterprises; however, vaccination strategies remain controversial and limited in efficacy with policy guidance evolving through professional bodies such as the World Small Animal Veterinary Association.

History and Research Advances

FIP was first characterized in mid‑20th century clinical reports compiled by veterinary pathologists and clinicians working in academic centers including Utrecht University and University of Glasgow. Subsequent decades saw advances in coronavirus molecular biology driven by laboratories at the Max Planck Institute and sequencing consortia like the European Bioinformatics Institute, informing spike protein mutation research and antiviral target identification. Recent translational research combining academic and industry partners—mirroring collaborations that produced therapies for other viral diseases at institutions such as the Scripps Research Institute—has produced candidate antivirals and refined diagnostic assays. Ongoing work in comparative immunology and genomics at centers including ETH Zurich and the University of Cambridge aims to consolidate prevention, diagnostic, and therapeutic strategies.

Category:Veterinary virology